Speaking at the RebelBio Demo Day in London, Emer O’Shea of Khonsu Therapeutics noted that although “short-term inflammation (acute) can oftentimes have a positive effect as it promotes healing, chronic inflammation can cause severe damage and is the basis for many diseases like multiple sclerosis, colitis, and arthritis. 6% of the world is affected by … Continue reading Khonsu Therapeutics to tackle inflammation with new drug – RebelBio Review